10.09.26 -- How AI Could Clear Logistics Roadblocks Limiting Patient Access To CGT

Low particulate control requires more than cleanrooms. See how monitoring, process controls, inspections, and validated testing support quality and compliance.

Examine five critical supply chain gaps in cell and gene therapy logistics that put patients at risk, from invisible operational burdens to reactive monitoring and fragmented coordination strategies.

Discover how ctDNA could transform early cancer detection and why the BRCA model offers important lessons for balancing innovation, risk, and meaningful patient outcomes.

Regulatory readiness for global expansion begins in Phase I. A development partner should design your trial and data collection to anticipate downstream regulatory requirements in your target regions.

Adaptive designs and biomarker tracking help early autoimmune trials find true signals despite complex, variable disease patterns.